412 related articles for article (PubMed ID: 18682503)
41. Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes.
Pitteloud N; Meysing A; Quinton R; Acierno JS; Dwyer AA; Plummer L; Fliers E; Boepple P; Hayes F; Seminara S; Hughes VA; Ma J; Bouloux P; Mohammadi M; Crowley WF
Mol Cell Endocrinol; 2006 Jul; 254-255():60-9. PubMed ID: 16764984
[TBL] [Abstract][Full Text] [Related]
42. The novel function of miR-3195 for mutant PROK2 (c.223-4C>A) degradation.
Zhou S; Li P
Cell Biol Int; 2021 Feb; 45(2):404-410. PubMed ID: 33140874
[TBL] [Abstract][Full Text] [Related]
43. Novel FGFR1 and KISS1R Mutations in Chinese Kallmann Syndrome Males with Cleft Lip/Palate.
Xu H; Niu Y; Wang T; Liu S; Xu H; Wang S; Liu J; Ye Z
Biomed Res Int; 2015; 2015():649698. PubMed ID: 26199944
[TBL] [Abstract][Full Text] [Related]
44. Clinical and genetic features of 64 young male paediatric patients with congenital hypogonadotropic hypogonadism.
Wang Y; Gong C; Qin M; Liu Y; Tian Y
Clin Endocrinol (Oxf); 2017 Dec; 87(6):757-766. PubMed ID: 28833369
[TBL] [Abstract][Full Text] [Related]
45. [GnRH deficiency: new insights from genetics].
Kottler ML; Hamel A; Malville E; Richard N
J Soc Biol; 2004; 198(1):80-7. PubMed ID: 15146960
[TBL] [Abstract][Full Text] [Related]
46. Pleiotropic effects of prokineticin 2 in the control of energy metabolism.
Magnan C; Migrenne-Li S
Biochimie; 2021 Jul; 186():73-81. PubMed ID: 33932486
[TBL] [Abstract][Full Text] [Related]
47. PROK2/PROKR2 Signaling and Kallmann Syndrome.
Dodé C; Rondard P
Front Endocrinol (Lausanne); 2013; 4():19. PubMed ID: 23596439
[TBL] [Abstract][Full Text] [Related]
48. Biallelic PROKR2 variants and congenital hypogonadotropic hypogonadism: a case report and a literature review.
Sugisawa C; Taniyama M; Sato T; Takahashi Y; Hasegawa T; Narumi S
Endocr J; 2022 Jul; 69(7):831-838. PubMed ID: 35236788
[TBL] [Abstract][Full Text] [Related]
49. Clinical assessment and molecular analysis of GnRHR and KAL1 genes in males with idiopathic hypogonadotrophic hypogonadism.
Versiani BR; Trarbach E; Koenigkam-Santos M; Dos Santos AC; Elias LL; Moreira AC; Latronico AC; de Castro M
Clin Endocrinol (Oxf); 2007 Feb; 66(2):173-9. PubMed ID: 17223984
[TBL] [Abstract][Full Text] [Related]
50. Functional analysis of the distal region of the third intracellular loop of PROKR2.
Zhou XT; Chen DN; Xie ZQ; Peng Z; Xia KD; Liu HD; Liu W; Su B; Li JD
Biochem Biophys Res Commun; 2013 Sep; 439(1):12-7. PubMed ID: 23969157
[TBL] [Abstract][Full Text] [Related]
51. Evidence of the importance of the first intracellular loop of prokineticin receptor 2 in receptor function.
Abreu AP; Noel SD; Xu S; Carroll RS; Latronico AC; Kaiser UB
Mol Endocrinol; 2012 Aug; 26(8):1417-27. PubMed ID: 22745195
[TBL] [Abstract][Full Text] [Related]
52. Prokineticins in central and peripheral control of human reproduction.
Traboulsi W; Brouillet S; Sergent F; Boufettal H; Samouh N; Aboussaouira T; Hoffmann P; Feige JJ; Benharouga M; Alfaidy N
Horm Mol Biol Clin Investig; 2015 Nov; 24(2):73-81. PubMed ID: 26574895
[TBL] [Abstract][Full Text] [Related]
53. Mutation screening of SEMA3A and SEMA7A in patients with congenital hypogonadotropic hypogonadism.
Känsäkoski J; Fagerholm R; Laitinen EM; Vaaralahti K; Hackman P; Pitteloud N; Raivio T; Tommiska J
Pediatr Res; 2014 May; 75(5):641-4. PubMed ID: 24522099
[TBL] [Abstract][Full Text] [Related]
54. Two novel mutations in the gonadotropin-releasing hormone receptor gene in Brazilian patients with hypogonadotropic hypogonadism and normal olfaction.
Costa EM; Bedecarrats GY; Mendonca BB; Arnhold IJ; Kaiser UB; Latronico AC
J Clin Endocrinol Metab; 2001 Jun; 86(6):2680-6. PubMed ID: 11397871
[TBL] [Abstract][Full Text] [Related]
55. Reversible congenital hypogonadotropic hypogonadism in patients with CHD7, FGFR1 or GNRHR mutations.
Laitinen EM; Tommiska J; Sane T; Vaaralahti K; Toppari J; Raivio T
PLoS One; 2012; 7(6):e39450. PubMed ID: 22724017
[TBL] [Abstract][Full Text] [Related]
56. Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia.
Raivio T; Avbelj M; McCabe MJ; Romero CJ; Dwyer AA; Tommiska J; Sykiotis GP; Gregory LC; Diaczok D; Tziaferi V; Elting MW; Padidela R; Plummer L; Martin C; Feng B; Zhang C; Zhou QY; Chen H; Mohammadi M; Quinton R; Sidis Y; Radovick S; Dattani MT; Pitteloud N
J Clin Endocrinol Metab; 2012 Apr; 97(4):E694-9. PubMed ID: 22319038
[TBL] [Abstract][Full Text] [Related]
57. Prokr2-deficient mice display vascular dysmorphology of the fetal testes: potential implications for Kallmann syndrome aetiology.
Svingen T; McClelland KS; Masumoto K; Sujino M; Nagano M; Shigeyoshi Y; Koopman P
Sex Dev; 2011; 5(6):294-303. PubMed ID: 22223120
[TBL] [Abstract][Full Text] [Related]
58. Genetics of congenital hypogonadotropic hypogonadism in Denmark.
Tommiska J; Känsäkoski J; Christiansen P; Jørgensen N; Lawaetz JG; Juul A; Raivio T
Eur J Med Genet; 2014 Jul; 57(7):345-8. PubMed ID: 24732674
[TBL] [Abstract][Full Text] [Related]
59. The prevalence of digenic mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome.
Quaynor SD; Kim HG; Cappello EM; Williams T; Chorich LP; Bick DP; Sherins RJ; Layman LC
Fertil Steril; 2011 Dec; 96(6):1424-1430.e6. PubMed ID: 22035731
[TBL] [Abstract][Full Text] [Related]
60. A mutation in the fibroblast growth factor receptor 1 gene causes fully penetrant normosmic isolated hypogonadotropic hypogonadism.
Xu N; Qin Y; Reindollar RH; Tho SP; McDonough PG; Layman LC
J Clin Endocrinol Metab; 2007 Mar; 92(3):1155-8. PubMed ID: 17200176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
